Hexarelin · Research brief

Hexarelin Price — Research-Grade Costs (2026)

Q: How does hexarelin work as a growth hormone secretagogue?

Hexarelin binds to growth hormone secretagogue receptor 1a (GHS-R1a) in the hypothalamus and pituitary gland, triggering intracellular signaling cascades that stimulate somatotroph cells to release growth hormone into circulation. Unlike GHRH (growth hormone-releasing hormone), which acts through cAMP pathways, hexarelin activates phospholipase C and calcium-dependent pathways that produce stronger, more sustained GH pulses. This mechanism makes hexarelin a valuable tool in receptor pharmacology studies examining GHS-R1a affinity, desensitization kinetics, and downstream signaling pathway activation.

Q: Can hexarelin be reconstituted with sterile water instead of bacteriostatic water?

Yes, but sterile water significantly shortens peptide stability post-reconstitution. Hexarelin reconstituted with sterile water should be used within 24–48 hours and stored at 2–8°C, as bacterial contamination risk increases without the 0.9% benzyl alcohol preservative present in bacteriostatic water. Bacteriostatic water extends reconstituted hexarelin stability to 28 days under refrigeration, making it the preferred diluent for multi-dose protocols where the same vial will be accessed repeatedly over weeks. For single-use applications where the entire vial is consumed immediately, sterile water is acceptable.

Q: What is the typical hexarelin price range for bulk research orders?

Bulk hexarelin orders (50mg or more) typically cost $60–$95 per 5mg vial at ≥95% purity, compared to $110–$180 per vial for small-quantity orders at ≥98% purity. The price reduction reflects economies of scale in synthesis and reduced per-unit QC documentation costs, but bulk orders should still include batch-specific certificates of analysis with HPLC and mass spec verification. Researchers ordering bulk quantities should request retention samples from the production batch to validate peptide quality before committing the full order to protocols — detecting synthesis errors after 100mg has been distributed across multiple studies is exponentially more disruptive than identifying issues during initial batch testing.

Q: What are the risks of using hexarelin with purity below 95 percent?

Hexarelin below 95% purity contains 5% or more impurities that can include truncated peptide fragments, deletion sequences, or synthesis byproducts like acetylated amino acids — these inactive materials occupy solution volume but don’t bind to GHS-R1a receptors, effectively reducing active dose by the impurity percentage. In dose-response studies, this creates rightward-shifted curves with elevated EC50 values that don’t match published data, making cross-study comparisons unreliable. Impurities can also introduce assay interference in spectrophotometric or fluorescence-based detection methods, creating false-positive signals or masking true receptor binding events. For protocols requiring precise pharmacokinetic measurements, peptide purity below 98% introduces unacceptable variability.

Q: How does hexarelin compare to other growth hormone secretagogues like GHRP-6?

Hexarelin and GHRP-6 both bind to GHS-R1a but differ in receptor affinity, selectivity, and ghrelin-mimetic activity. Hexarelin demonstrates higher GHS-R1a affinity (EC50 0.5–2.0 nM) compared to GHRP-6 (EC50 10–50 nM), producing stronger GH release at equivalent molar doses. However, hexarelin shows greater cross-reactivity with CD36 scavenger receptors in cardiac tissue, which has been documented in cardiovascular pharmacology studies as a potential off-target effect. GHRP-6 exhibits stronger ghrelin-like appetite stimulation due to higher hypothalamic GHS-R1a activation relative to pituitary signaling. For receptor pharmacology studies focused purely on GH secretion mechanisms, hexarelin offers superior potency; for appetite regulation or metabolic studies, GHRP-6 provides a more balanced ghrelin-mimetic profile.

Q: What storage temperature is required for hexarelin before reconstitution?

Lyophilized hexarelin must be stored at −20°C before reconstitution to maintain long-term peptide stability and prevent oxidative degradation of methionine and tryptophan residues at positions 2 and 4. Storage at 2–8°C (standard refrigeration) is acceptable for short-term holding (up to 90 days), but extended storage at this temperature increases aggregation risk and gradual loss of receptor binding potency. Room temperature storage (20–25°C) is not recommended beyond 48 hours, as peptide degradation accelerates measurably above 15°C even in lyophilized form. Once reconstituted with bacteriostatic water, hexarelin must be refrigerated at 2–8°C and used within 28 days — freezing reconstituted peptide solutions causes irreversible aggregation and should be avoided.

Q: Why does hexarelin price vary so much between suppliers?

Hexarelin price variation reflects differences in synthesis method (solid-phase vs liquid-phase peptide synthesis), purity specification (≥95% vs ≥99%), batch size (small-batch vs bulk production), and quality control documentation (batch-specific HPLC and MS vs generic COA). Suppliers using SPPS with Fmoc chemistry and per-batch verification charge $110–$180 per 5mg vial because this method produces peptides with <2% impurities and reproducible receptor binding profiles across batches. Budget suppliers achieve $45–$85 pricing through liquid-phase synthesis or contract manufacturing without disclosed QC, which reduces upfront costs but increases peptide variability and impurity rates to 5–12%. The price difference reflects the cost of synthesis transparency and batch-to-batch reproducibility — critical factors in research applications where assay consistency depends on peptide quality.

Q: What documentation should accompany research-grade hexarelin?

Research-grade hexarelin should include a batch-specific certificate of analysis (COA) containing HPLC chromatogram with retention time and purity quantification, mass spectrometry data confirming molecular weight (887.04 Da), amino-acid analysis verifying sequence accuracy, and storage/handling recommendations. The HPLC chromatogram should show a single dominant peak representing the target peptide with integration area corresponding to stated purity (e.g., ≥98%), plus identification of any minor impurity peaks. Mass spec data should confirm the peptide molecular weight matches theoretical calculations for the hexapeptide sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2. Suppliers who cannot provide this documentation within 48 hours of request are either reselling peptides they didn’t synthesize or operating without adequate quality control — both scenarios create traceability gaps that compromise research integrity.

Q: Can hexarelin lose potency during shipping?

Yes, if shipping conditions exceed recommended temperature ranges. Lyophilized hexarelin can tolerate ambient temperature (up to 25°C) for 48–72 hours without significant degradation, but prolonged exposure above 30°C during summer shipping or storage in non-climate-controlled warehouses accelerates peptide oxidation and aggregation. Most specialized peptide suppliers ship with cold packs or temperature-monitoring devices to ensure peptides remain below 25°C during transit — this adds $8–$15 to hexarelin price but prevents temperature-induced potency loss. Upon receipt, verify that any included temperature indicator hasn’t been triggered; if the peptide was exposed to temperatures above 30°C for more than 24 hours, request a replacement batch rather than risk using compromised material in your protocol.

Q: What is the optimal reconstitution concentration for hexarelin?

The optimal reconstitution concentration for hexarelin depends on intended dose volumes and assay sensitivity, but 1–2mg/mL in bacteriostatic water is standard for most research applications. This concentration allows accurate pipetting of microliter volumes (5–50 µL per dose) while maintaining peptide stability for 28 days at 2–8°C. Higher concentrations (3–5mg/mL) are acceptable for storage volume reduction but increase aggregation risk over time, particularly if the solution undergoes multiple freeze-thaw cycles. Lower concentrations (<0.5mg/mL) improve long-term stability but require larger injection volumes that may be impractical for rodent models or high-throughput screening assays. For receptor binding studies, match reconstitution concentration to the dynamic range of your detection method — fluorescence polarization assays typically require 0.1–1.0mg/mL, while radioligand displacement assays work well at 0.5–2.0mg/mL.

Real Peptides Research TeamEditorial

Updated March 30, 202611 min read

43 WORDS

Short answer

Key takeaways

Hexarelin price ranges from $45 to $180 per 5mg vial depending on purity (≥95% to ≥99%), synthesis method (SPPS vs liquid-phase), and batch quality control documentation.
SPPS-synthesized hexarelin with HPLC verification costs $85–$120 per vial at ≥98% purity and produces coefficient of variation rates below 8% in GH release assays, compared to 18%+ for liquid-phase material.
Small-batch synthesis with lyophilization at −40°C to −50°C under <100 mTorr vacuum prevents peptide aggregation during reconstitution and maintains solution clarity for 28+ days at 2–8°C.
Hexarelin requires exact amino-acid sequencing at His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 to achieve documented GHS-R1a receptor affinity. A single substitution reduces binding by 40–80%.
Batch-specific certificates of analysis with HPLC and mass spec data eliminate variability risk and allow direct comparison to published pharmacokinetic studies without correction factors.
Peptides sold at ≥95% purity contain up to 5% impurities (truncated fragments, deletion sequences) that occupy solution volume but don't bind to target receptors, effectively reducing active dose by the impurity percentage.

The hexarelin price listed on most supplier sites tells you almost nothing about what you're actually buying. Research published in the Journal of Pharmaceutical Sciences found that peptide degradation rates can vary by as much as 300% between batches synthesized under different conditions. Making the procurement decision less about finding the lowest price and more about verifying synthesis integrity before your first reconstitution.

We've supplied research-grade peptides to hundreds of institutions across cutting-edge metabolic and endocrine research protocols. The gap between a reliable hexarelin source and a problematic one comes down to three factors most procurement teams never verify: amino-acid sequencing precision, lyophilization temperature control, and post-synthesis purity verification.

What determines hexarelin price for research applications?

Hexarelin price for research-grade material ranges from $45 to $180 per vial depending on peptide purity (≥95% to ≥99%), batch synthesis method (solid-phase peptide synthesis versus liquid-phase), and quantity ordered. Higher-purity peptides synthesized through small-batch SPPS with HPLC verification cost more upfront but deliver reproducible receptor binding assays and consistent pharmacokinetic profiles across repeated trials.

Most researchers assume hexarelin price reflects nothing more than markup variation across suppliers. That's incorrect. The pricing structure for research peptides is directly tied to synthesis protocols, purification steps, and quality control documentation that determine whether your binding affinity data will replicate or whether you'll spend six months troubleshooting assay inconsistencies that trace back to peptide impurities you never knew existed. Hexarelin. A growth hormone secretagogue peptide (GHSP) that binds to growth hormone secretagogue receptors (GHS-R1a). Requires exact amino-acid sequencing at positions His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 to achieve the receptor affinity documented in published trials. A single substitution at any position degrades binding affinity by 40–80%, turning a $90 peptide into an expensive saline control. This article covers how hexarelin price correlates with synthesis quality, what procurement red flags signal unreliable material, and how to verify peptide integrity before committing to a supplier.

Synthesis Method Drives Hexarelin Price Variation

Hexarelin price differences of $60–$100 per vial between suppliers often reflect whether the peptide was synthesized using solid-phase peptide synthesis (SPPS) with Fmoc chemistry or outdated liquid-phase methods that introduce higher impurity rates. SPPS allows amino acids to be added sequentially to a growing peptide chain anchored to a solid resin. Each coupling step is verified before the next residue is added, which minimizes deletion sequences (missing amino acids) and substitution errors that compromise receptor binding. Liquid-phase synthesis, while cheaper to execute at scale, produces peptides with 5–12% impurity rates even after purification, because side reactions and incomplete couplings are harder to control in solution.

The hexarelin price for SPPS-synthesized material typically starts at $85–$120 per 5mg vial at ≥98% purity. Material synthesized through liquid-phase methods or contract manufacturers operating without in-house HPLC verification can be found for $45–$65 per vial, but that cost advantage disappears the moment you discover batch-to-batch variability in your dose-response curves. We've tested peptides from suppliers across both synthesis categories. SPPS material consistently produces tighter standard deviations in GH release assays (CV <8%), while liquid-phase peptides show coefficient of variation rates above 18%, making statistical significance harder to achieve without doubling sample sizes.

Purity certification matters more than the hexarelin price listed on the product page. Peptides sold at ≥95% purity contain up to 5% impurities. Those impurities can include truncated peptide fragments, deletion sequences, or acetylated side products that don't bind to GHS-R1a but do occupy volume in your reconstituted solution. A vial labeled as 5mg at 95% purity contains approximately 4.75mg of active hexarelin and 0.25mg of inactive material. If your protocol is calibrated for 5mg total peptide and you don't adjust for purity, your effective dose is 5% lower than intended. Enough to shift IC50 values in competitive binding assays or flatten dose-response slopes in secretagogue studies. Hexarelin price for ≥99% purity material runs $140–$180 per 5mg vial, but that specification eliminates most impurity-driven variability and allows direct comparison to published pharmacokinetic data without correction factors.

Batch Size and Lyophilization Standards Impact Cost

Small-batch synthesis. Defined as peptide runs producing fewer than 50 vials per batch. Costs more per unit than bulk production, but it enables tighter quality control at every synthesis and purification stage. The hexarelin price for small-batch material typically includes per-batch HPLC and mass spectrometry verification, which confirms that every vial in that production run matches the target amino-acid sequence and purity specification. Bulk synthesis spreads QC costs across thousands of vials, reducing per-unit expense but increasing the statistical likelihood that a subset of vials contains out-of-spec material that passed through without individual verification.

Lyophilization (freeze-drying) is the process that converts liquid peptide solution into the stable powder form shipped to research labs. Hexarelin must be lyophilized under controlled vacuum and temperature conditions (typically −40°C to −50°C under <100 mTorr pressure) to preserve tertiary structure and prevent aggregation during reconstitution. Suppliers who cut costs by lyophilizing at higher temperatures or insufficient vacuum introduce microaggregates. Clumps of peptide molecules that don't fully dissolve when reconstituted with bacteriostatic water. These aggregates reduce bioavailable peptide concentration and create particle interference in spectrophotometric assays. The hexarelin price difference between properly lyophilized peptides and cost-reduced variants is usually $20–$30 per vial, but the functional difference is whether your reconstituted solution remains clear or develops visible cloudiness within 48 hours of mixing.

Real Peptides synthesizes Hexarelin using small-batch SPPS with exact amino-acid sequencing verified through HPLC and mass spec before lyophilization at −45°C under <80 mTorr vacuum. Every batch ships with third-party purity certification and reconstitution stability data. Documentation that matters when you're six months into a receptor pharmacology study and need to confirm that batch-to-batch consistency hasn't introduced confounding variables. The hexarelin price reflects that synthesis precision, but the real cost is measured in reproducible data and eliminated troubleshooting time.

Hexarelin Price: Supplier Comparison

The hexarelin price you pay depends on whether you're sourcing from a peptide-specialized supplier with in-house synthesis and QC, a contract manufacturer reselling bulk peptides under different labels, or a general chemical distributor carrying peptides as one category among thousands. Below is a structured comparison of how synthesis transparency, purity specifications, and batch documentation correlate with pricing tiers.

Supplier Type	Hexarelin Price (5mg)	Purity Specification	Synthesis Method Disclosed	Batch-Specific COA Provided	Bottom Line
Peptide-Specialized (In-House Synthesis)	$110–$180	≥98–99%	SPPS with Fmoc chemistry	Yes. HPLC, MS per batch	Highest reproducibility; batch traceability eliminates guesswork
Contract Reseller (Third-Party Synthesis)	$70–$110	≥95–98%	Often undisclosed	Sometimes. Generic COA	Mid-tier pricing; variability risk if synthesis source changes
General Chemical Distributor	$45–$85	≥90–95%	Rarely disclosed	Rarely. COA on request only	Lowest upfront cost; highest risk of impurities and poor reconstitution
Research Institution Bulk Order	$60–$95	≥95%	Disclosed if requested	Yes. For orders >50mg	Cost-effective for large studies; requires validation before first use

The hexarelin price differential between a peptide-specialized supplier and a general distributor is typically $65–$95 per vial, but that gap represents the cost of synthesis transparency and reproducibility assurance. If your protocol depends on precise GH secretagogue dose-response curves or competitive receptor binding studies, peptides synthesized without disclosed methods or batch-specific documentation introduce uncontrolled variables that no amount of statistical correction can eliminate. We've evaluated peptides across all four supplier categories. In-house synthesis with per-batch verification consistently outperforms resold or bulk-distributed material in reconstitution clarity, stability at 2–8°C post-mixing, and assay reproducibility across independent trials.

What If: Hexarelin Price Scenarios

What If the Hexarelin Price Is Significantly Lower Than Market Average?

Verify synthesis method and request batch-specific HPLC data before purchasing. Hexarelin priced below $60 per 5mg vial typically indicates liquid-phase synthesis, bulk reselling without in-house QC, or purity specifications below ≥95%. Any of which introduce impurity-driven variability that compromises receptor binding assays and dose-response reproducibility. Peptides synthesized without disclosed methods or third-party verification may contain deletion sequences (missing amino acids at positions 2, 4, or 6) that reduce GHS-R1a affinity by 50–70%, turning your binding study into an underpowered trial with uninterpretable results. The hexarelin price difference of $40–$60 per vial between budget suppliers and verified sources is recovered within one eliminated troubleshooting cycle. Failed assays cost more in reagent waste and lost research time than the peptide procurement savings ever offset.

What If Batch Documentation Isn't Provided with the Hexarelin Purchase?

Request a certificate of analysis (COA) with HPLC chromatogram and mass spectrometry data before using the peptide in any protocol. Suppliers who don't provide batch-specific documentation either don't perform per-batch verification or are reselling peptides synthesized by undisclosed third parties. Both scenarios create traceability gaps that make it impossible to determine whether assay failures result from protocol errors or peptide quality issues. A valid COA for hexarelin includes retention time data showing a single dominant peak at the expected molecular weight (887.04 Da for the hexapeptide) and purity quantification above the claimed specification. If your supplier can't provide this within 48 hours of request, the hexarelin price. Regardless of how competitive. Isn't worth the risk of compromised data integrity.

What If the Reconstituted Hexarelin Develops Cloudiness or Precipitate?

Discard the vial immediately and contact the supplier. Cloudiness indicates peptide aggregation from improper lyophilization or storage temperature excursions above 8°C. Properly synthesized hexarelin reconstituted with sterile bacteriostatic water at 1–2mg/mL remains clear and colorless for 28 days when stored at 2–8°C. Aggregated peptides don't dissolve fully, which reduces bioavailable concentration and introduces particle interference in UV spectrophotometry or fluorescence-based assays. The aggregation is irreversible. No amount of vortexing or warming will restore solution clarity once tertiary structure has collapsed. This failure mode is most common with peptides lyophilized at insufficient vacuum (<100 mTorr minimum required) or synthesized with incomplete coupling steps that create hydrophobic microdomains prone to self-association. The hexarelin price you paid is unrecoverable, but switching to a supplier with disclosed lyophilization parameters prevents recurrence.

The Hard Truth About Hexarelin Price

Here's the honest answer: the lowest hexarelin price almost never delivers the best value for research applications. Peptides are biologics. Their function depends entirely on precise amino-acid sequence, tertiary structure stability, and freedom from truncation or substitution errors. You can't verify any of those with the naked eye, which means the only reliable quality signal is synthesis transparency and batch-specific documentation. Suppliers who compete on price alone typically achieve that advantage by eliminating the synthesis steps and verification protocols that ensure reproducibility. They're not selling you hexarelin at a discount, they're selling you a peptide mixture with an unknown percentage of active material and hoping your assay isn't sensitive enough to detect the difference.

The hexarelin price that matters isn't the per-vial cost on the invoice. It's the total cost per reproducible data point. A $65 peptide that introduces 18% coefficient of variation in your GH secretion assay requires nearly triple the sample size to achieve statistical significance compared to a $120 peptide with <8% CV. When you factor in reagent costs, animal model expenses, or cell culture time, the budget peptide costs more per usable result even though it costs less per milligram. Real Peptides prices hexarelin based on what it costs to synthesize it correctly. Small-batch SPPS, verified sequencing, controlled lyophilization, and third-party purity certification. That's not a premium markup; it's the baseline cost of producing peptides that behave predictably across independent trials.

Every research protocol we've supported follows the same pattern: investigators who prioritize hexarelin price over synthesis documentation spend weeks troubleshooting assay variability that traces back to peptide quality, then switch to verified suppliers and immediately see tighter dose-response curves and reproducible receptor binding kinetics. The peptide procurement decision happens once per study; the consequences of that decision ripple through every data point collected afterward. Choose based on what you need the peptide to do, not what you want to pay for it.

Verifying Hexarelin Quality Beyond Price

The hexarelin price tells you what the supplier charges. It doesn't tell you what the peptide does once reconstituted. Quality verification for research peptides requires documentation that most general distributors either don't generate or don't disclose. Before committing to a supplier, request the following: (1) HPLC chromatogram showing retention time and purity quantification for the specific batch you're purchasing, (2) mass spectrometry data confirming molecular weight matches the expected value (887.04 Da for hexarelin), (3) amino-acid analysis verifying sequence accuracy at all six positions, and (4) lyophilization protocol documentation including vacuum pressure and temperature parameters. Suppliers who provide all four without hesitation are synthesizing peptides in-house with robust QC. Suppliers who can't provide any of them are reselling material they didn't produce and can't verify.

Reconstitution stability is the functional test that reveals synthesis quality after purchase. Properly synthesized hexarelin remains stable in bacteriostatic water at 2mg/mL for 28 days at 2–8°C without visible aggregation, precipitation, or color change. Test a small aliquot (50–100 µL) immediately after reconstitution and again at 7-day intervals. If the solution develops cloudiness, particulates, or yellow discoloration, the peptide was either improperly lyophilized or stored above recommended temperature during shipping. This test costs nothing beyond the peptide itself and provides direct evidence of whether the material will remain stable throughout your protocol timeline. We've received peptides from competitors that failed this test within 72 hours of reconstitution despite being sold at premium hexarelin price points. Synthesis method matters more than brand reputation.

Binding affinity validation is the definitive quality test for hexarelin but requires access to GHS-R1a receptor assays. Published data shows hexarelin binds to GHS-R1a with EC50 values between 0.5–2.0 nM in competitive displacement assays using [125I]-labeled ghrelin as the radioligand. If your hexarelin produces EC50 values above 5 nM or shows shallow dose-response slopes (Hill coefficients <0.8), the peptide likely contains impurities or deletion sequences that reduce receptor affinity. This test isn't practical for every lab, but it's the only way to confirm that the peptide you purchased performs identically to the hexarelin referenced in published literature. Institutions running long-term studies should validate at least one batch through receptor binding before committing to multi-vial procurement.

Real Peptides supplies every hexarelin order with batch-specific HPLC and mass spec documentation plus reconstitution stability guidance. The hexarelin price includes synthesis transparency as a standard component, not an optional add-on. You can verify peptide quality before the first injection, not six weeks into a failed protocol. That traceability is what separates research-grade material from peptides synthesized to hit a price target without regard for functional performance.

The hexarelin price you pay upfront matters less than the peptide's performance across the full study timeline. Peptides that degrade after 14 days, produce inconsistent dose-response data, or introduce unexplained variability don't become acceptable just because they cost $50 less per vial. Procurement decisions based on synthesis transparency and batch verification deliver reproducible results; decisions based on the lowest listed price deliver troubleshooting cycles. If your protocol depends on precise GH secretagogue pharmacology, the only hexarelin price worth considering is the one attached to peptides you can verify.

Questions